CDC issues travel notice for Manitoba hepatitis A outbreak

The U.S. Centers for Disease Control and Prevention has issued a travel notice for Manitoba in response to a yearlong hepatitis A outbreak in the Canadian province, urging travelers to ensure they are vaccinated before visiting affected communities.

Travel notice highlights growing cross-border health concern

According to publicly available information from the U.S. agency’s travelers’ health resources, Manitoba has been added to the list of destinations with special travel advice linked to infectious disease risks. The notice follows a sustained increase in locally acquired hepatitis A cases in the province, with alerts circulating widely on public health monitoring forums and regional news coverage on June 17, 2026.

The advisory positions Manitoba alongside a small group of destinations where travelers are urged to take additional precautions, particularly around food and water safety and vaccination status. While the notice is not a call to avoid travel altogether, it recommends that unvaccinated visitors consult a health provider before departure and consider receiving hepatitis A vaccine if they plan to spend time in communities affected by the outbreak.

Reports indicate that the move reflects concern about ongoing person to person transmission in Manitoba and the potential for infected travelers to carry the virus back to the United States. Travel health notices of this kind are designed to alert clinicians and the public that routine pre trip advice may not be sufficient when visiting certain regions during an active outbreak.

Discussion of the Manitoba notice quickly spread across social platforms dedicated to infectious disease tracking, where users shared screenshots of the travel alert and compared it with earlier advisories that had focused mainly on destinations in Latin America, Africa, or Asia. The appearance of a Canadian province on that list has drawn attention to the dynamics of vaccine preventable disease in high income settings.

Manitoba’s prolonged outbreak and who is most affected

Manitoba public health updates describe an outbreak that began in early 2025 and has steadily expanded across multiple regions of the province. Government bulletins and provider letters posted online in 2025 and 2026 detail hundreds of outbreak related cases, with laboratory analysis indicating a common strain circulating in the community.

Recent provincial documents show that as of mid April 2026 more than 500 outbreak linked infections had been recorded, with new cases still being added in the months that followed. Online summaries shared through Canadian public health alerts and local media reports indicate at least several deaths associated with the outbreak, underscoring the potential severity of hepatitis A in adults and in people with underlying health conditions.

Published information from Manitoba authorities highlights that the burden has fallen disproportionately on northern First Nations communities and on people experiencing homelessness or unstable housing in urban centres such as Winnipeg. Several First Nations communities have been singled out in provincial notices that expand access to publicly funded hepatitis A vaccine, reflecting localized clusters within the broader provincial outbreak.

Health agency postings indicate that while many infections are mild or self limiting, a significant share of patients require hospitalization for acute liver inflammation, and a small number have progressed to liver failure. These outcomes have prompted stronger messaging around early vaccination, particularly for individuals who may have difficulty accessing clean water, sanitation, or consistent medical care.

Expanded vaccination campaigns in northern and high risk communities

In response to the outbreak, Manitoba has issued a series of letters to health care providers and community leaders that are publicly available through the provincial health department’s website. These documents show a stepwise expansion of vaccine eligibility, beginning with certain northern First Nations in 2025 and broadening through 2026 to include additional communities and people whose work or household contacts connect them to affected areas.

One April 2026 bulletin notes that as of mid April more than 540 outbreak associated cases had been reported, prompting the province to extend free hepatitis A vaccination to residents of War Lake First Nation and to anyone traveling to or working in that community. Similar letters reference earlier expansions for First Nations in the Island Lake region and for Peguis First Nation, reflecting how the outbreak has moved between geographically distinct populations.

Further updates posted in May and June 2026 refine eligibility once again, adding communities such as Cross Lake and clarifying that people experiencing homelessness or using shelters in Winnipeg qualify for vaccination under an existing high risk immunization program. Manitoba materials emphasize that for the purposes of outbreak control, one dose of hepatitis A vaccine is currently prioritized to cover as many eligible people as possible, with the option to revisit two dose schedules at a later stage.

Regional public health alerts from neighboring jurisdictions, including northwestern Ontario, advise clinicians to ask patients about recent travel to Manitoba or to specific First Nations communities when assessing suspected hepatitis A cases. These cross border communications, together with the new U.S. travel notice, illustrate how a provincial outbreak can have wider implications for surrounding regions and for international travelers.

What the CDC notice means for travelers to Manitoba

The U.S. travel notice does not restrict entry into Manitoba or recommend cancelling trips, but it raises the baseline level of caution for anyone planning to visit the province. Travelers are advised in publicly accessible CDC materials to ensure they are fully vaccinated against hepatitis A before departure, especially if they are likely to stay with friends or relatives, visit smaller communities, or have close contact with local residents.

Hepatitis A is typically spread through the fecal oral route, often via contaminated food or water or through close personal contact with an infected person. The virus has an incubation period that averages about four weeks, which means individuals can be infected during travel and only develop symptoms after returning home. For that reason, travel health notices emphasize that vaccination before exposure is the most reliable way to reduce the risk.

Online educational resources from both Manitoba and U.S. agencies note that symptoms can range from fatigue, nausea, and abdominal pain to jaundice and dark urine. While most people recover fully, adults are more likely than children to experience severe illness, and people with chronic liver disease face a higher risk of complications. The CDC’s standard travel guidance for hepatitis A recommends vaccine for most unvaccinated travelers to areas experiencing outbreaks, including parts of North America when public health authorities flag elevated risk.

Travelers are also encouraged to follow basic hygiene practices such as frequent handwashing, careful handling of food and drinking water, and avoiding close contact with anyone known to be ill. Publicly available guidance suggests that individuals who develop symptoms of hepatitis A during or after a trip to Manitoba should seek medical advice and inform their provider about their recent travel and potential exposure.

Implications for tourism and local response

The travel notice arrives at the start of the busy summer season, when Manitoba typically welcomes visitors for its lakes, festivals, and outdoor recreation. Tourism operators and local businesses are monitoring developments closely, as travelers weigh the new health advisory against long standing plans for family visits, fishing trips, or cultural events.

Past experience with similar notices in other destinations suggests that travel advisories tied to vaccine preventable diseases often lead to questions rather than immediate cancellations. Many travelers adjust by seeking vaccination and clarifying the level of risk in the specific areas they plan to visit. In Manitoba’s case, publicly available information indicates that the outbreak has been most intense in particular communities and among defined high risk groups, rather than evenly spread across the entire province.

Provincial materials point to ongoing collaboration between local health services, community leadership, and federal partners to expand vaccination, improve access to clean water and sanitation, and provide education on how hepatitis A spreads. Those efforts, together with increased awareness driven by the U.S. travel notice, may help limit further transmission by encouraging both residents and visitors to update their immunizations.

For international travelers, the Manitoba outbreak serves as a reminder that familiar destinations can still present evolving health risks. The new notice encourages a more deliberate approach to pre travel preparation, including confirming routine vaccines, reviewing destination specific advice, and considering how travel plans intersect with communities that may be under greater strain from a prolonged infectious disease event.